Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Hallucinogens: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>LockPicker
m wording
>Blackhole
m Reverted edits by Kai (talk) to last revision by David Hedlund
 
(76 intermediate revisions by 12 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
'''Hallucinogens''' are a class of [[psychoactive substances]] that produce powerful alterations in perception, mood, and various cognitive processes.<ref>Nichols, D. E. (2004). Hallucinogens. Pharmacology & therapeutics, 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002</ref> Hallucinogens represent one of the three major classes of psychoactive substances: the other two are [[stimulants]] ("uppers") and [[depressants]] ("downers"). However, hallucinogens are claimed to be distinct from stimulants and depressants in that they do not merely amplify or dull existing states of consciousness but instead produce qualitatively unique states in which the environment and self are perceived in a new fashion.
 
'''Hallucinogens''' are a class of [[psychoactive substances]] that produce powerful alterations in perception, mood, and various cognitive processes.<ref>{{cite journal | vauthors=((Nichols, D. E.)) | journal=Pharmacology & Therapeutics | title=Hallucinogens | volume=101 | issue=2 | pages=131–181 | date= February 2004 | url=https://linkinghub.elsevier.com/retrieve/pii/S0163725803001657 | issn=01637258 | doi=10.1016/j.pharmthera.2003.11.002}}</ref> Hallucinogens represent one of the three major classes of psychoactive substances: the other two are [[stimulants]] ("uppers") and [[depressants]] ("downers").  
 
Some claim hallucinogens can be fundamentally distinguished from stimulants and depressants. Rather than merely amplifying or dulling existing states of consciousness, they are said to produce qualitatively unique states, in which the environment and self are perceived in a new fashion.
   
   
Notably, hallucinogens are commonly reported to be able to facilitate self-understanding and self-discovery. Hallucinogenic experiences are often compared to non-ordinary forms of consciousness such as [[lucid dreaming]], [[meditation]], religious, mystical or [[transpersonal]] experiences, [[hallucinations]], and states of [[psychosis]].  
A notable aspect of hallucinogens — particularly psychedelics — is that they are often reported to be able to facilitate introspective or therapeutic processes. Hallucinogenic experiences are often compared to non-ordinary forms of consciousness such as [[lucid dreaming]], trance [[meditation]], [[hallucinations]], [[dreams]], and states of [[psychosis]].  


Hallucinogens can be classified into three categories:  
Hallucinogens can be classified into three categories:  
*'''[[psychedelics]]''' (e.g. [[LSD]], [[psilocybin mushrooms]], [[DMT]], etc.)
*'''[[psychedelics]]''' (e.g. [[LSD]], [[psilocybin mushrooms]], [[DMT]], etc.)
*'''[[dissociatives]]''' (e.g. [[ketamine]], [[PCP]], [[DXM]], etc.)  
*'''[[dissociatives]]''' (e.g. [[ketamine]], [[PCP]], [[DXM]], etc.)
*'''[[deliriants]]''' (e.g. [[DPH]], [[scopolamine]], [[datura]], etc)  
*'''[[deliriants]]''' (e.g. [[DPH]], [[scopolamine]], [[datura]], etc)
 
Each category is associated with a unique mechanism of action, subjective effects, therapeutic properties, abuse potential, and toxicity risks.
 
Hallucinogens that have a history of [[transpersonal|spiritual or shamanic experiences]] are known as [[entheogen]]s.


Each category is associated with a unique mechanism of action, subjective effects, therapeutic potential, and health risks. It is highly advised to use [[harm reduction practices]] if using these substances.
Despite what their names suggest, most hallucinogens induce pseudo-hallucinations rather than 'true' hallucinations (i.e. which cannot be distinguished from normal reality). Pseudohallucinations, on the other hand, are recognized as such by the user.<ref>{{cite journal|last1=Telles-Correia|first1=Diogo|last2=Moreira|first2=Ana Lúcia|last3=Gonçalves|first3=João S.|title=Hallucinations and related concepts—their conceptual background|journal=Frontiers in Psychology|volume=6|pages=991|year=2015|issn=1664-1078|doi=10.3389/fpsyg.2015.00991|pmid=26283978|pmc=4515540|oclc=701805890}}</ref> These are common with psychedelics and dissociatives, while 'true' hallucinations are usually induced by deliriants.


Despite their name, most hallucinogens rather induce pseudohallucinations than 'real' halluciantions, which cannot be distinguished from normal reality. Pseudohallucinations, on the other hand, are recognised as such by the user.<ref>{{cite journal|last1=Telles-Correia|first1=Diogo|last2=Moreira|first2=Ana Lúcia|last3=Gonçalves|first3=João S.|title=Hallucinations and related concepts—their conceptual background|journal=Frontiers in Psychology|volume=6|pages=991|year=2015|issn=1664-1078|doi=10.3389/fpsyg.2015.00991|pmid=26283978|pmc=4515540|oclc=701805890}}</ref> These are common with psychedelics and dissociatives, while 'real' hallucinations are induced by deliriants in most cases.
It is highly advised to use [[harm reduction practices]] if using these substances.


==List of hallucinogens==
==List of hallucinogens==
Line 39: Line 47:
<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Base Tryptamines]]</h4>
<h4 class="media-heading">[[Base Tryptamines]]</h4>
* [[DMT]]
*[[DMT]]
* [[MET]]
*[[MET]]
* [[DET]]
*[[DET]]
* [[MPT]]
*[[MPT]]
* [[EPT]]
*[[EPT]]
* [[DPT]]
*[[DPT]]
* [[DiPT]]
*[[DiPT]]
* [[MiPT]]
*[[MiPT]]
* [[EiPT]]
*[[EiPT]]
* [[PiPT]]
*[[PiPT]]
* [[aMT]]
*[[aMT]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Substituted Tryptamines]]</h4>
<h4 class="media-heading">[[Substituted Tryptamines]]</h4>
* [[4-AcO-DET]] (''Ethacetin'')
*[[4-AcO-DET]] (''Ethacetin'')
* [[4-AcO-DMT]] (''Psilacetin'')
*[[4-AcO-DMT]] (''Psilacetin'')
* [[4-AcO-DPT]]
*[[4-AcO-DPT]] (''Pracetin'')
* [[4-AcO-DiPT]] (''Ipracetin'')
*[[4-AcO-DiPT]] (''Ipracetin'')
* [[4-AcO-EPT]]
*[[4-AcO-EPT]] (''Epracetin'')
* [[4-AcO-MET]] (''Metacetin'', ''Azomet'')
*[[4-AcO-MET]] (''Metacetin'', ''Azomet'')
* [[4-AcO-MPT]]
*[[4-AcO-MPT]] (''Mepracetin'')
* [[4-AcO-MiPT]] (''Mipracetin'')
*[[4-AcO-MiPT]] (''Mipracetin'')
* [[4-HO-DET]] (''Ethocin'')
*[[4-HO-DET]] (''Ethocin'')
* [[4-HO-DMT]] (''Psilocin'')
*[[4-HO-DMT]] (''Psilocin'')
* [[4-HO-DPT]]
*[[4-HO-DPT]] (''Procin'')
* [[4-HO-DiPT]] (''Iprocin'')
*[[4-HO-DiPT]] (''Iprocin'')
* [[4-HO-EPT]]
*[[4-HO-EPT]] (''Eprocin'')
* [[4-HO-MET]] (''Metocin'')
*[[4-HO-MET]] (''Metocin'')
* [[4-HO-MPT]]
*[[4-HO-MPT]] (''Meprocin'')
* [[4-HO-MiPT]] (''Miprocin'')
*[[4-HO-MiPT]] (''Miprocin'')
* [[4-PO-DMT]] (''Psilocybin'')
*[[4-PO-DMT]] (''Psilocybin'')
* [[5-HO-DMT]] (''Bufotenin'')
*[[5-HO-DMT]] (''Bufotenin'')
* [[5-MeO-DALT]]
*[[5-MeO-DALT]] (''Foxtrot'')
* [[5-MeO-DMT]]
*[[5-MeO-DMT]]
* [[5-MeO-DiPT]] (''Foxy'')
*[[5-MeO-DiPT]] (''Foxy'')
* [[5-MeO-MALT]]
*[[5-MeO-MALT]]
* [[5-MeO-MiPT]] (''Moxy'')
*[[5-MeO-MiPT]] (''Moxy'')
* [[Ibogaine]]
*[[Ibogaine]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Phenethylamines]]</h4>
<h4 class="media-heading">[[Phenethylamines]]</h4>
* [[Allylescaline]]
*[[Allylescaline]]
* [[Escaline]]
*[[Escaline]]
* [[Mescaline]]
*[[Mescaline]]
* [[Methallylescaline]]
*[[Methallylescaline]]
* [[Proscaline]]
*[[Proscaline]]
</li>
 
<li class="featured list-item">
<h4 class="media-heading">[[2C-x]] series</h4>
*[[2C-B]]
*[[2C-C]]
*[[2C-D]]
*[[2C-E]]
*[[2C-H]]
*[[2C-G-5]]
*[[2C-I]]
*[[2C-P]]
*[[ßk-2C-B]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[2C-x]]</h4>
<h4 class="media-heading">[[2C-T-x]] series</h4>
* [[2C-B]]
*[[2C-T]]
* [[2C-B-FLY]]
*[[2C-T-2]]
* [[2C-C]]
*[[2C-T-21]]
* [[2C-D]]
*[[2C-T-7]]
* [[2C-E]]
* [[2C-H]]
* [[2C-G-5]]
* [[2C-I]]
* [[2C-P]]
* [[2C-T-2]]
* [[2C-T-21]]
* [[2C-T-7]]
* [[ßk-2C-B]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[DOx]]</h4>
<h4 class="media-heading">[[DOx]] series</h4>
* [[DOB]]
*[[DOB]]
* [[DOC]]
*[[DOC]]
* [[DOI]]
*[[DOI]]
* [[DOM]]
*[[DOM]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[25x-NBOMe]]</h4>
<h4 class="media-heading">[[25x-NBOMe]] series</h4>
* [[25B-NBOMe]]
*[[25B-NBOMe]]
* [[25C-NBOMe]]
*[[25C-NBOMe]]
* [[25D-NBOMe]]
*[[25D-NBOMe]]
* [[25I-NBOMe]]
*[[25I-NBOMe]]
* [[25N-NBOMe]]
*[[25N-NBOMe]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[25x-NBOH]]</h4>
<h4 class="media-heading">[[25x-NBOH]] series</h4>
* [[25B-NBOH]]
*[[25B-NBOH]]
* [[25C-NBOH]]
*[[25C-NBOH]]
* [[25I-NBOH]]
*[[25I-NBOH]]
</li>
 
<li class="featured list-item">
<h4 class="media-heading">[[Benzofurans]]</h4>
*[[2C-B-FLY]]
*[[5-MeO-DiBF]]
*[[Bromo-DragonFLY]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">Others</h4>
<h4 class="media-heading">Others</h4>
* [[3C-E]]
*[[3C-E]]
* [[5-MeO-DiBF]]
*[[Efavirenz]]
* [[Bromo-DragonFLY]]
*[[TMA-2]]
* [[Efavirenz]]
*[[TMA-6]]
* [[TMA-2]]
* [[TMA-6]]
</li>
</li>


Line 147: Line 164:
<ul class="featured-table">
<ul class="featured-table">
<li class="featured list-item">
<li class="featured list-item">
* [[Acacia confusa]]
*[[Acacia confusa]]
* [[Amanita muscaria (mycology)| Amanita muscaria]]
*[[Amanita muscaria]]
* [[Ayahuasca]]
*[[Ayahuasca]]
* [[Banisteriopsis caapi]]
*[[Banisteriopsis caapi]]
* [[Cannabis]]
*[[Brugmansia]]
* [[Chacruna]]
*[[Cannabis]]
* [[Datura]]
*[[Chacruna]]
* [[Hawaiian baby woodrose]]
*[[Datura]]
* [[Iboga]]
*[[Hawaiian baby woodrose]]
* [[Mimosa hostilis]]
*[[Iboga]]
* [[Morning glory]]
*[[Mimosa hostilis]]
* [[Psilocybe mushroom]]
*[[Morning glory]]
* [[Psychedelic cacti]]
*[[Psilocybe mushroom]]
* [[Salvia divinorum]]
*[[Psychedelic cacti]]
* [[Syrian rue]]
*[[Salvia divinorum]]
* [[Yopo]]
*[[Syrian rue]]
*[[Yopo]]
</li>
</li>


Line 191: Line 209:
<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Morphinan]]s</h4>
<h4 class="media-heading">[[Morphinan]]s</h4>
* [[Dextromethorphan]] (''DXM'')
*[[Dextromethorphan]] (''DXM'')
* [[Dextrorphan]] (''DXO'')
*[[Dextrorphan]] (''DXO'')
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Diarylethylamines]]</h4>
<h4 class="media-heading">[[Diarylethylamines]]</h4>
* [[Diphenidine]]
*[[Diphenidine]]
* [[Ephenidine]]
*[[Ephenidine]]
* [[Methoxphenidine]] (''MXP'')
*[[Methoxphenidine]] (''MXP'')
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">Others</h4>
<h4 class="media-heading">Others</h4>
* [[Ibogaine]]
*[[Ibogaine]]
* [[Memantine]]
*[[Memantine]]
* [[Nitrous oxide]]
*[[Nitrous oxide]]
* [[Xenon]]
*[[Xenon]]
</li>
</li>


Line 219: Line 237:
<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Tropane alkaloids]]</h4>
<h4 class="media-heading">[[Tropane alkaloids]]</h4>
* [[Atropine]]
*[[Atropine]]
* [[Hyoscyamine]]
*[[Hyoscyamine]]
* [[Scopolamine]]
*[[Scopolamine]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Antihistamines]]</h4>
<h4 class="media-heading">[[Antihistamines]]</h4>
* [[Diphenhydramine]]
*[[Diphenhydramine]]
* [[Doxylamine]]
*[[Doxylamine]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">Others</h4>
<h4 class="media-heading">Others</h4>
* [[Benzydamine]]
*[[Benzydamine]]
* [[Elemicin]]
*[[Elemicin]]
* [[Mirtazapine]]
*[[Mirtazapine]]
* [[Myristicin]]
*[[Myristicin]]
</li>
</li>


Line 247: Line 265:
<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[Cannabinoid#Phytocannabinoids|Phytocannabinoid]]s</h4>
<h4 class="media-heading">[[Cannabinoid#Phytocannabinoids|Phytocannabinoid]]s</h4>
* [[Cannabinol]] (''CBN'')
*[[Cannabinol]] (''CBN'')
* [[Tetrahydrocannabinol]] (''THC'')
*[[Tetrahydrocannabinol]] (''THC'')
</li>
</li>


Line 275: Line 293:
<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[GABA|GABA-A receptor agonists]]</h4>
<h4 class="media-heading">[[GABA|GABA-A receptor agonists]]</h4>
* [[Muscimol]]
*[[Muscimol]]
* [[Z-drug|Z-drugs]]
*[[Z-drug|Z-drugs]]
** [[Zaleplon]]
**[[Zaleplon]]
** [[Zopiclone]]
**[[Zopiclone]]
** [[Zolpidem]]
**[[Zolpidem]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[κ-opioid receptor agonists]]</h4>
<h4 class="media-heading">[[κ-opioid receptor agonists]]</h4>
* [[Ibogaine]]
*[[Ibogaine]]
* [[Mirtazapine]]
*[[Mirtazapine]]
* [[Salvinorin A]]
*[[Salvinorin A]]
* [[Salvinorin B]]
*[[Salvinorin B]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">[[β-Carbolines]]</h4>
<h4 class="media-heading">[[β-Carbolines]]</h4>
* [[Harmaline]]
*[[Harmaline]]
* [[Harmine]]
*[[Harmine]]
* [[Tetrahydroharmine]]
*[[Tetrahydroharmine]]
</li>
</li>


<li class="featured list-item">
<li class="featured list-item">
<h4 class="media-heading">Combinations</h4>
<h4 class="media-heading">Combinations</h4>
* [[Ayahuasca]]
*[[Ayahuasca]]
</li>
</li>


Line 307: Line 325:


==See also==
==See also==
*[[Responsible use]]
*[[Responsible use]]
*[[Psychonautics]]
*[[Psychonautics]]
Line 314: Line 333:


==External links==
==External links==
*[https://www.wikipedia.org/wiki/hallucinogens Hallucinogens (Wikipedia)]
*[https://www.wikipedia.org/wiki/hallucinogens Hallucinogens (Wikipedia)]


==Literature==
==Literature==
*Nichols, D. E. (2004). Hallucinogens. Pharmacology & therapeutics, 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002
*Nichols, D. E. (2004). Hallucinogens. Pharmacology & therapeutics, 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002


Line 325: Line 346:
[[Category:Psychoactive class]]
[[Category:Psychoactive class]]
[[Category:Hallucinogen|*]]
[[Category:Hallucinogen|*]]
{{#set:Featured=true}}

Latest revision as of 17:20, 2 June 2024


Hallucinogens are a class of psychoactive substances that produce powerful alterations in perception, mood, and various cognitive processes.[1] Hallucinogens represent one of the three major classes of psychoactive substances: the other two are stimulants ("uppers") and depressants ("downers").

Some claim hallucinogens can be fundamentally distinguished from stimulants and depressants. Rather than merely amplifying or dulling existing states of consciousness, they are said to produce qualitatively unique states, in which the environment and self are perceived in a new fashion.

A notable aspect of hallucinogens — particularly psychedelics — is that they are often reported to be able to facilitate introspective or therapeutic processes. Hallucinogenic experiences are often compared to non-ordinary forms of consciousness such as lucid dreaming, trance meditation, hallucinations, dreams, and states of psychosis.

Hallucinogens can be classified into three categories:

Each category is associated with a unique mechanism of action, subjective effects, therapeutic properties, abuse potential, and toxicity risks.

Hallucinogens that have a history of spiritual or shamanic experiences are known as entheogens.

Despite what their names suggest, most hallucinogens induce pseudo-hallucinations rather than 'true' hallucinations (i.e. which cannot be distinguished from normal reality). Pseudohallucinations, on the other hand, are recognized as such by the user.[2] These are common with psychedelics and dissociatives, while 'true' hallucinations are usually induced by deliriants.

It is highly advised to use harm reduction practices if using these substances.

List of hallucinogens

See also

Literature

References

  1. Nichols, D. E. (February 2004). "Hallucinogens". Pharmacology & Therapeutics. 101 (2): 131–181. doi:10.1016/j.pharmthera.2003.11.002. ISSN 0163-7258. 
  2. Telles-Correia, Diogo; Moreira, Ana Lúcia; Gonçalves, João S. (2015). "Hallucinations and related concepts—their conceptual background". Frontiers in Psychology. 6: 991. doi:10.3389/fpsyg.2015.00991. ISSN 1664-1078. OCLC 701805890. PMC 4515540Freely accessible. PMID 26283978.